This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kato, T. Articles by Ogawa, S. Search for Related Content PubMed PubMed Citation Articles by Kato, T. Articles by Ogawa, S. Related Collections Cell signalling/signal transduction Growth factors/cytokines Ion channels/membrane transport Signal transduction

(Circulation Research. 2000;87:937.)
© 2000 American Heart Association, Inc.

Integrative Physiology

Calmodulin Kinases II and IV and Calcineurin Are Involved in Leukemia Inhibitory Factor–Induced Cardiac Hypertrophy in Rats

Takahiro Kato¹, Motoaki Sano¹, Shunichiro Miyoshi, Toshihiko Sato, Daihiko Hakuno, Hideyuki Ishida, Hiroe Kinoshita-Nakazawa, Keiichi Fukuda, Satoshi Ogawa

From the Cardiopulmonary Division, Department of Internal Medicine (T.K., M.S., S.M., T.S., D.H., K.F., S.O.), Keio University, Tokyo, Japan, and Department of Physiology (H.I., H.K.-N.), Tokai University, Kanagawa, Japan.

Correspondence to Keiichi Fukuda, MD, PhD, Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail kfukuda{at}mc.med.keio.ac.jp

Abstract—We recently reported that leukemia inhibitory factor (LIF) enhances Ca²⁺]_i through an increase in L-type Ca²⁺ current (I_Ca,L) in adult cardiomyocytes. The aim of this study was to investigate whether LIF activates Ca²⁺-dependent signaling molecules, such as calcineurin and calmodulin kinases II and IV (CaMKII and CaMKIV), and, if so, whether these Ca²⁺-mediated signaling events contribute to LIF-mediated cardiac hypertrophy. We first confirmed that LIF increased I_Ca,L and [Ca²⁺]_i in primary cultured rat neonatal cardiomyocytes. Calcineurin, CaMKII, and CaMKIV activities increased at 2 minutes and peaked by 1.6-, 2.2-, and 2.2-fold, respectively, at 15 minutes. Nicardipine or verapamil fully inhibited these activities. Autophosphorylation of CaMKII was also observed to parallel the timing of CaMKII activity, and this phosphorylation was blocked by nicardipine, verapamil, or EGTA. LIF treatment led to a 3-fold increase in nuclear factor of activated T cell–luciferase activity. To confirm that inositol triphosphate (IP₃)-induced Ca²⁺ release from sarcoplasmic reticulum was not involved in this process, IP₃ content and phosphorylation of phospholipase C were investigated. LIF did not increase IP₃ content or phosphorylate phospholipase C. KN62 (an inhibitor of CaMKII and CaMKIV) attenuated c-fos, brain natriuretic peptide, -skeletal actin, and atrial natriuretic peptide expression. KN62 suppressed the LIF-induced increase in [³H]phenylalanine uptake and cell size. Cyclosporin A and FK506 slightly attenuated brain natriuretic peptide but did not affect c-fos or atrial natriuretic peptide expression. Cyclosporin A significantly reduced the LIF-induced increase in [³H]phenylalanine uptake. These findings indicated that LIF activated CaMKII, CaMKIV, and calcineurin through an increase in I_Ca,L and [Ca²⁺]_i and that CaMKII, CaMKIV, and calcineurin are critically involved in LIF-induced cardiac hypertrophy.

Key Words: leukemia inhibitory factor • calcium • calmodulin-dependent kinase • calcineurin • cardiac hypertrophy

This article has been cited by other articles:

				J. R. Somers, P. L. Beck, J. P. Lees-Miller, D. Roach, Y. Li, J. Guo, S. Loken, S. Zhan, L. Semeniuk, and H. J. Duff iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1122 - H1131. [Abstract] [Full Text] [PDF]

				J. Backs and E. N. Olson Control of Cardiac Growth by Histone Acetylation/Deacetylation Circ. Res., January 6, 2006; 98(1): 15 - 24. [Abstract] [Full Text] [PDF]

				U. Rueckschloss and G. Isenberg Contraction augments L-type Ca2+ currents in adherent guinea-pig cardiomyocytes J. Physiol., October 15, 2004; 560(2): 403 - 411. [Abstract] [Full Text] [PDF]

				S. Chang, T. A. McKinsey, C. L. Zhang, J. A. Richardson, J. A. Hill, and E. N. Olson Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development Mol. Cell. Biol., October 1, 2004; 24(19): 8467 - 8476. [Abstract] [Full Text] [PDF]

				B. Fiedler and K. C Wollert Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes Cardiovasc Res, August 15, 2004; 63(3): 450 - 457. [Abstract] [Full Text] [PDF]

				T. Zhang and J. H. Brown Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure Cardiovasc Res, August 15, 2004; 63(3): 476 - 486. [Abstract] [Full Text] [PDF]

				R. Vlasblom, A. Muller, R. J.P Musters, M. J Zuidwijk, C. van Hardeveld, W. J Paulus, and W. S Simonides Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes Cardiovasc Res, August 15, 2004; 63(3): 537 - 544. [Abstract] [Full Text] [PDF]

				N. N Petrashevskaya, I. Bodi, S. E Koch, S. A Akhter, and A. Schwartz Effects of {alpha}1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression Cardiovasc Res, August 15, 2004; 63(3): 561 - 572. [Abstract] [Full Text] [PDF]

				E. Takahashi, K. Fukuda, S. Miyoshi, M. Murata, T. Kato, M. Ita, T. Tanabe, and S. Ogawa Leukemia Inhibitory Factor Activates Cardiac L-Type Ca2+ Channels via Phosphorylation of Serine 1829 in the Rabbit Cav1.2 Subunit Circ. Res., May 14, 2004; 94(9): 1242 - 1248. [Abstract] [Full Text] [PDF]

				T. Zhang, S. Miyamoto, and J. H. Brown Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes? Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168. [Abstract] [Full Text]

				D. A. Linseman, C. M. Bartley, S. S. Le, T. A. Laessig, R. J. Bouchard, M. K. Meintzer, M. Li, and K. A. Heidenreich Inactivation of the Myocyte Enhancer Factor-2 Repressor Histone Deacetylase-5 by Endogenous Ca2//Calmodulin-dependent Kinase II Promotes Depolarization-mediated Cerebellar Granule Neuron Survival J. Biol. Chem., October 17, 2003; 278(42): 41472 - 41481. [Abstract] [Full Text] [PDF]

				J. M. Colomer, L. Mao, H. A. Rockman, and A. R. Means Pressure Overload Selectively Up-Regulates Ca2+/Calmodulin-Dependent Protein Kinase II in Vivo Mol. Endocrinol., February 1, 2003; 17(2): 183 - 192. [Abstract] [Full Text] [PDF]

				M. A. Sussman, A. McCulloch, and T. K. Borg Dance Band on the Titanic: Biomechanical Signaling in Cardiac Hypertrophy Circ. Res., November 15, 2002; 91(10): 888 - 898. [Abstract] [Full Text] [PDF]

				B. Fiedler, S. M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, F. Schroder, J. D. Molkentin, H. Drexler, and K. C. Wollert Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes PNAS, August 20, 2002; 99(17): 11363 - 11368. [Abstract] [Full Text] [PDF]

				B. J Wilkins and J. D Molkentin Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? J. Physiol., May 15, 2002; 541(1): 1 - 8. [Abstract] [Full Text] [PDF]

				O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF]

				S. Tahara, K. Fukuda, H. Kodama, T. Kato, S. Miyoshi, and S. Ogawa Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1554 - 1563. [Abstract] [Full Text] [PDF]